Amit Taneja - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Amit Taneja

Showing results (31-40 of 34) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 34 results.

BMJ Quality & Safety|August 9, 2017

Controlled trial to improve resident sign-out in a medical intensive care unitRahul Nanchal, Brian Aebly, Gabrielle Graves, et al.

Chest|August 20, 2011

Nationwide trends of severe sepsis in the 21st century (2000-2007)Gagan Kumar, Nilay Kumar, Amit Taneja, et al.

Science (New York, N.Y.)|September 20, 2008

An inhibitor of FtsZ with potent and selective anti-staphylococcal activityDavid J Haydon, Neil R Stokes, Rebecca Ure, et al.

JAMA|May 9, 2023

Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical TrialsToby M Maher, Paul Ford, Kevin K Brown, et al.

Pageof 4

Search research articles

Showing results (31-40 of 34) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 34 results.

BMJ Quality & Safety|August 9, 2017

Controlled trial to improve resident sign-out in a medical intensive care unitRahul Nanchal, Brian Aebly, Gabrielle Graves, et al.

Chest|August 20, 2011

Nationwide trends of severe sepsis in the 21st century (2000-2007)Gagan Kumar, Nilay Kumar, Amit Taneja, et al.

Science (New York, N.Y.)|September 20, 2008

An inhibitor of FtsZ with potent and selective anti-staphylococcal activityDavid J Haydon, Neil R Stokes, Rebecca Ure, et al.

JAMA|May 9, 2023

Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical TrialsToby M Maher, Paul Ford, Kevin K Brown, et al.

Pageof 4